The Zhitong Finance App learned that in the Hong Kong stock market on March 22, Beishui made a net purchase of 3,074 million yuan, of which the Hong Kong Stock Connect (Shanghai) transaction made a net purchase of HK$1,726 million and the Hong Kong Stock Connect (Shenzhen) transaction made a net purchase of HK$1,347 million.
The individual stocks that Beishui Clean bought the most were Profit Fund (02800), Hang Seng China Enterprises (02828), and Tencent (00700). The largest individual stocks sold by Beishui Clean were SMIC (00981), China Construction Bank (00939), and CNOOC (00883).
Hong Kong Stock Connect (Shanghai) actively traded stocks
Hong Kong Stock Connect (Shenzhen) actively traded stocks
Tencent (00700) received a net purchase of HK$536 million. According to the news, Tencent released its results after the market. Fourth quarter revenue was 145 billion yuan, up 1% year on year; adjusted net profit was 29.7 billion yuan, up 19% year on year. According to Tencent Holdings, revenue in 2022 was 554.55 billion yuan, a year-on-year decrease of 1%. Net profit for the year was 188.24 billion yuan, down 16% from the previous year, and estimated at 113.66 billion yuan.
Bilibili-SW (09626) received a net purchase of HK$225 million. According to the news, on March 20, the State Press and Publication Administration announced the approval results for the first batch of imported online game versions in 2023, “Shine!” by Bilibili's agent The edition of “A Beautiful Girl” was approved. Goldman Sachs said that the Japanese version of the mobile game was the highest-grossing mobile game for iOS in Japan in 2021. It had already generated about 1 billion yuan in revenue in the first month after its release, reaching 300 million yuan on February 23.
Beishui Capital continues to increase its holdings in telecommunications stocks. China Telecom (00728) and China Mobile (00941) received net purchases of HK$217 million and HK$130 million respectively. According to the news, China Telecom released its annual results after the market, achieving revenue of 474.967 billion yuan in 2022, an increase of 9.4% over the previous year; net profit attributable to shareholders of listed companies was 27.593 billion yuan, an increase of 6.3% over the previous year. Zhongyuan Securities said earlier that as the main force developing the digital economy, the growth rate of operators' performance continues to improve, and the high dividend rates of telecom operators form steady support for mid-term valuation levels. Explore the establishment of a valuation system with Chinese characteristics, and continue to be optimistic about the revaluation of telecom operators.
Kuaishou-W (01024) received a net purchase of HK$140 million. According to the news, Orient Securities released a research report saying that in January, the country introduced a number of policies to promote the economy and steady growth, promoting a steady recovery in economic operations at the beginning of the year. With the liberalization of epidemic control and the end of the peak period of infection, domestic food and beverage consumption resumed positive growth, improving sharply from month to month. The recovery trend of online growth in January-February was upward. From the perspective of express delivery, it is expected that the industry will recover significantly in March. I recommend Kuaishou, an e-commerce platform for emerging content.
Medicinal Biology (02269) received a net purchase of HK$49.42 million. According to the news, Medicinal Biotech will release its results today. CITIC Construction Investment said that it will downplay short-term investment and financing fluctuations and is optimistic about the long-term development of CRO. On the demand side, domestic innovative drugs will continue to develop. At the same time, domestic CRO can also serve the world and gain more global share; on the supply side, the number of domestic graduates is huge and continues to send talents to CRO companies. Pre-clinical experimental animals are rich in gene-edited mice, and leading companies also have good control over experimental monkeys, which is conducive to the development of pre-clinical CRO; the domestic population base is large and the number of patients is large, which also facilitates clinical CRO.
In terms of Hong Kong stock ETFs, Profit Fund (02800), Hang Seng China Enterprises (02828), and Southern Hang Seng Technology (03033) received net purchases of HK$1,084 million, 584 million, and HK$435 million respectively. In terms of individual stocks, SMIC (00981), China Construction Bank (00939), and CNOOC (00883) received net sales of 254 million, 241 million, and HK$37.1 million respectively.